Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  8, 1276 - 1280 (2002)
Published online: 7 October 2002; | doi:10.1038/nm787


There is a Corrigendum (January 2003) associated with this Article.

Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis

Richard Sharp1, 5, Juan A. Recio1, 5, Chamelli Jhappan1, Toshiyuki Otsuka1, Shiquan Liu1, Yanlin Yu1, Wenjing Liu1, Miriam Anver2, Fariba Navid3, Lee J. Helman3, Ronald A. DePinho4 & Glenn Merlino1

1  Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland, USA

2  Pathology/Histotechnology Laboratory, SAIC, Frederick Cancer Research and Development Center, Frederick, Maryland, USA

3  Pediatric Branch, National Cancer Institute, Bethesda, Maryland, USA

4  Department of Adult Oncology, Medicine and Genetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA

5  R.S. and J.A.R. contributed equally to this study.

Correspondence should be addressed to Glenn Merlino gmerlino@helix.nih.gov
Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children, yet molecular events associated with the genesis and progression of this potentially fatal disease are largely unknown. For the molecules and pathways that have been implicated, genetic validation has been impeded by lack of a mouse model of RMS. Here we show that simultaneous loss of Ink4a/Arf function and disruption of c-Met signaling in Ink4a/Arf -/- mice transgenic for hepatocyte growth factor/scatter factor (HGF/SF) induces RMS with extremely high penetrance and short latency. In cultured myoblasts, c-Met activation and Ink4a/Arf loss suppress myogenesis in an additive fashion. Our data indicate that human c-MET and INK4a/ARF, situated at the nexus of pathways regulating myogenic growth and differentiation, represent critical targets in RMS pathogenesis. The marked synergism in mice between aberrant c-Met signaling and Ink4a/Arf inactivation, lesions individually implicated in human RMS, suggests a therapeutic combination to combat this devastating childhood cancer.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
Ultraviolet radiation and cutaneous malignant melanoma
Oncogene Reviews (19 May 2003)
 See all 11 matches for Reviews

NEWS AND VIEWS
Muscling in on rhabdomyosarcoma
Nature Medicine News and Views (01 Nov 2002)
p53: only ARF the story
Nature Cell Biology News and Views (01 Mar 2000)

RESEARCH
Rhabdomyosarcoma – working out the pathways
Oncogene Original Article (22 Sep 1999)
PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells
British Journal of Cancer Original Article (21 Jul 2003)
 See all 80 matches for Research

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
See also: News and Views by Cavenee
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2002 Nature Publishing Group | Privacy policy